AKBA

0.38558.71%
MW

Michael W. Rogers

Independent Director

Mr. Michael W. Rogers, also known as Mike, B.A., M.B.A., served as Chief Financial Officer at Apnimed, Inc. since 2021 until June 2024. Mr. Rogers served as Director at Aravive, Inc. since September 15, 2020 until January 17, 2024. Mr. Rogers has been an Independent Director of Akebia Therapeutics, Inc. since December 12, 2018. He served as the Chief Financial Officer of Aerpio Pharmaceuticals, Inc. since May 14, 2019 until October 15, 2019. Mr. Rogers served as the Chief Financial & Business Officer and Principal Financial & Accounting Officer at Aerpio Pharmaceuticals, Inc. until October 15, 2019. He served as the Chief Financial Officer of Aerpio Pharmaceuticals, Inc. since November 2017 to May 2019. Mr. Rogers was the Chairman at Keryx Biopharmaceuticals, Inc. since September 2017 until December 12, 2018. Mr. Rogers served as the Chief Financial Officer of Acorda Therapeutics, Inc. from October 07, 2013 to October 4, 2016 and served as its Principal Accounting Officer. Mr. Rogers served as Consultant to healthcare companies from October 4, 2016 to December 31, 2016. He served as the Chief Financial Officer, Executive Vice President and Treasurer of BG Medicine, Inc. from June 2009 to October 18, 2012. He has biopharmaceutical industry experience. He served as an Executive Vice President, Chief Financial Officer and Treasurer of Endo Pharmaceuticals Solutions Inc. since February 1999. From February 1998 to December 1998, he served as an Executive Vice President and Chief Financial and Corporate Development Officer of Advanced Health Corporation. Mr. Rogers was an investment banker at Lehman Brothers and PaineWebber, where he focused on life sciences companies. From July 1995 to November 1997, he served as a Vice President, Chief Financial Officer and Treasurer of AutoImmune Inc. Mr. Rogers joined Acorda with experience in the biopharmaceutical industry. Mr. Rogers has experience in the biopharmaceutical industry, serving as Chief Financial Officer of five publicly-traded healthcare companies. Mr. Rogers served as Executive Vice President, Chief Financial Officer and Treasurer of Indevus Pharmaceuticals, Inc. from February 1999 to April 2009. From July 1994 to July 1995, he served as Vice President, Investment Banking at Lehman Brothers Inc. From 1990 to 1994, he was associated with PaineWebber Inc. and served as its Vice President of Investment Banking Division. He was Non-Executive Director of EyePoint Pharmaceuticals, Inc. since July 27, 2005 until June 2019. He was an Independent Director of Keryx Biopharmaceuticals Inc. since March 2016 until December 12, 2018. He serves as a Non-Executive Director of Eyepoint Pharmaceuticals US, Inc. He served as a Director of Biotie Therapies Corp. since May 11, 2016 until December 2016. He served as a Director at Coronado Biosciences, Inc. (now known as Fortress Biotech, Inc.) from May 2011 to December 2013. Mr. Rogers holds an M.B.A. from the Darden School of Business at the University of Virginia and a B.A. in Political Science from Union College.

Positions